Patients with acute myocardial infarction in Northern Italy are often infected by Helicobacter pylori

Panminerva Medica

Volumn 41, Issue , 1999, Pages 279-282

  Pellicano, R ^a   Parravicini, P P ^a   Bigi, R ^b   La Rovere, M T ^a   Baduini, G ^c   Gandolfo, N ^c   Casaccia, M ^b   Reforzo, F ^d   Santoriello, L ^d   Aruta, E ^e   Marenco, G ^d   Arena, V ^a   Bazzoli, F ^f   Rizzetto, M ^a   Ponzetto, A ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b Morelli Hospital   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d Pietra Ligure Hospital   (Italy)

^e S GIOVANNI BOSCO HOSPITAL   (Italy)

^f NONE

Author keywords

Coronary disease; Helicobacter infection; Helicobacter pylori; Myocardial infarction; Myocardial ischemia

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; HEART INFARCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ITALY; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0033251098     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76.
2. Shaper AG, Pocock SJ, Walker M, Phillips AN, Whitehead TP, MacFarlane PW. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epid Comm Health 1985;39:197-209.
3. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;26:719-34.
4. Patel P, Mendall MA, Carrington D, Strachan D, Leatham E, Molineaux N et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-4.
5. Whincup PH, Mendall MA, Perry IJ, Strachan D, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996;75: 568-72.
6. Rathbone B, Martin D, Stephens, J, Thompson JR, Samani NJ. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart 1996;76:308-11.
7. Morgando A, Sanseverino P, Perotto C, Molino F, Gai V, Ponzetto A. Helicobacter pylori seropositivity in myocardial infarction. Lancet 1995;345:1380.
8. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9.
9. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607-8.
10. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60.
11. Ross R. Atherosclerosis- An inflammatory disease N Engl J Med 1999;340:115-26.
12. Gasbarrini A, Ponzetto A, Franceschi F, Pellicano R, Gasbarrini G. Helicobacter pylori infection and extradigestive diseases. Curr Opin Gastroenterol 1998;14(suppl.1):S65-S69.
13. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
14. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
15. Patel P, Carrington D, Strachan D, Leatham E, Goggin P, Northfield TC et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994;343:1634-5.
16. Anderson JL, Carlquist JF, Muhlestein JB, Horne BJ, Elmer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. JACC 1998;32:35-41.
17. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998; 316:1130-2.
18. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A et al. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999;137:346-51.
19. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100:996-1005.
20. Markle HV. Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status. Med Hypotheses 1997;49:289-92.
21. Sung JJY, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease Heart 1996;76:305-7.
22. Birnie DH, Holme ER, McKay IC, Hood S, McColl KEL, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Eur Heart J 1998;19:387-94.
23. Broutet N, Pellicano R. Helicobacter pylori et pathologies cardiovasculaires. Lettre de L'infectiologue 1999;3(suppl.1):32-7.
24. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997;314: 1317-8.
25. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JWG, Sweetnam PM et al. Relation of infection to 13-year mortality and incident ischemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation 1998;98:1286-90.
26. Ponzetto A, La Rovere MT, Sanseverino P, Bazzoli F. Study confirms previous findings. BMJ 1996;312:251.
27. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
28. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivor of myocardial infarction. Circulation 1997;96:404-7.
29. Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P. Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. Ann Med 1998;30:481-7.
30. Braunwald E. Shattuck letture- Cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities. N Engl J Med 1997;337:1360-9.